Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aging, longevity, inflammation, and cancer.

Calogero Caruso1, Domenico Lio, Luca Cavallone

  • 1Gruppo di Studio sull'Immunosenescenza, Dipartimento di Biopatologia e Metodologie Biomediche, Università di Palermo, Italy.

Annals of the New York Academy of Sciences
|May 27, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Polyphenol-Rich Olive Oil Byproduct-Derived Nutraceutical Preserves Muscle Health in Adults at Metabolic Risk: A Secondary Analysis of a Pilot Study.

Nutrients·2026
Same author

The need to increase support for healthy ageing and longevity research in the EU by establishing a Coordination and Support Programme on Healthy Ageing and Longevity.

Mechanisms of ageing and development·2026
Same author

Editorial: Immunity in aging and age-related diseases and dysfunctions.

Frontiers in immunology·2025
Same author

Refining Nutritional Assessment Methods for Older Adults: A Pilot Study on Sicilian Long-Living Individuals.

Nutrients·2025
Same author

Enhancing flu vaccine responses in older adults: preliminary insights from the ISOLDA study on immunosenescence and antioxidant and anti-inflammatory approaches.

Immunity & ageing : I & A·2025
Same author

Immune-Inflammatory Response in Lifespan-What Role Does It Play in Extreme Longevity? A Sicilian Semi- and Supercentenarians Study.

Biology·2025

Centenarians show cancer resistance, possibly due to specific cytokine gene variants. High IL-6 or low IL-10 production aids pathogen resistance but may worsen cancer outcomes, while the opposite aids longevity.

Area of Science:

  • Immunology
  • Genetics
  • Gerontology

Background:

  • Cancer incidence rises with age, but plateaus or declines after 85-90 years.
  • Centenarians exhibit remarkable resistance to cancer, suggesting underlying protective mechanisms.
  • The inflammatory response, involving cytokines like IL-6 and IL-10, influences tumor progression and host survival.

Purpose of the Study:

  • To explore the role of cytokine gene polymorphisms in cancer resistance and longevity.
  • To investigate the dual role of inflammatory genotypes in disease and aging.
  • To understand the potential antagonistic pleiotropy of IL-6 and IL-10 in cancer and lifespan.

Main Methods:

  • Literature review of studies on cancer, aging, and cytokine gene polymorphisms.
  • Analysis of data linking specific genotypes (IL-6, IL-10) to clinical outcomes and lifespan.

Related Experiment Videos

  • Examination of the evolutionary implications of inflammatory responses.

    • Main Results:

    • Pro-inflammatory genotypes with low IL-10 or high IL-6 are associated with worse cancer outcomes.
    • Conversely, high IL-10 producer genotypes are more prevalent in centenarians.
    • High IL-6 production correlates with reduced lifespan, while high IL-10 is linked to longevity.

    Conclusions:

    • Cytokine gene polymorphisms (IL-6, IL-10) exhibit antagonistic pleiotropy, impacting both cancer risk and longevity.
    • Genotypes promoting pathogen resistance (high IL-6/low IL-10) may increase cancer susceptibility.
    • Genotypes favoring controlled inflammation (low IL-6/high IL-10) may enhance cancer protection and promote longevity.